795 related articles for article (PubMed ID: 29673738)
21. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
22. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
[TBL] [Abstract][Full Text] [Related]
23. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
24. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
[TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
Front Immunol; 2018; 9():1957. PubMed ID: 30210502
[No Abstract] [Full Text] [Related]
27. Phosphorylation of aryl hydrocarbon receptor interacting protein by TBK1 negatively regulates IRF7 and the type I interferon response.
Kazzaz SA; Shaikh KA; White J; Zhou Q; Powell WH; Harhaj EW
J Biol Chem; 2024 Jan; 300(1):105525. PubMed ID: 38043800
[TBL] [Abstract][Full Text] [Related]
28. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
29. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients.
Murayama G; Chiba A; Kuga T; Makiyama A; Yamaji K; Tamura N; Miyake S
Rheumatology (Oxford); 2020 Oct; 59(10):2992-3002. PubMed ID: 32160289
[TBL] [Abstract][Full Text] [Related]
30. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
[TBL] [Abstract][Full Text] [Related]
31. CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.
Pan M; Hu T; Lyu J; Yin Y; Sun J; Wang Q; Xu L; Hu H; Wang C
Autophagy; 2024 Feb; 20(2):311-328. PubMed ID: 37723657
[TBL] [Abstract][Full Text] [Related]
32. Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression.
Chikhalya A; Dittmann M; Zheng Y; Sohn SY; Rice CM; Hearing P
mBio; 2021 Dec; 12(6):e0282921. PubMed ID: 34724821
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
35. Cytokine-induced STAT1 activation is increased in patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Immunol; 2016 Apr; 165():60-7. PubMed ID: 26995659
[TBL] [Abstract][Full Text] [Related]
36. Porcine Epidemic Diarrhea Virus nsp15 Antagonizes Interferon Signaling by RNA Degradation of TBK1 and IRF3.
Wu Y; Zhang H; Shi Z; Chen J; Li M; Shi H; Shi D; Guo L; Feng L
Viruses; 2020 May; 12(6):. PubMed ID: 32486349
[TBL] [Abstract][Full Text] [Related]
37. Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
Bodewes ILA; van der Spek PJ; Leon LG; Wijkhuijs AJM; van Helden-Meeuwsen CG; Tas L; Schreurs MWJ; van Daele PLA; Katsikis PD; Versnel MA
Front Immunol; 2019; 10():312. PubMed ID: 30863411
[No Abstract] [Full Text] [Related]
38. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
Front Immunol; 2019; 10():2096. PubMed ID: 31552042
[TBL] [Abstract][Full Text] [Related]
39. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren's syndrome.
Thorlacius GE; Wahren-Herlenius M; Rönnblom L
Curr Opin Rheumatol; 2018 Sep; 30(5):471-481. PubMed ID: 29889694
[TBL] [Abstract][Full Text] [Related]
40. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
